Completed PHASE1 INTERVENTIONAL 3-arm NCT01755247

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

A Phase One, Single-Center, Open-Label, Randomized, Parallel Group, 3 Day Study Evaluating the Safety and Cutaneous Tolerability of NVN10000 Topical Gel in Healthy Volunteers

Sponsor: Novan, Inc.

Conditions Acne Vulgaris

Interventions 8% NVN1000 Topical Gel 8% NVN1000 Topical Gel and moisturizer Topical Gel Vehicle

Updated 7 times since 2017 Last updated: Sep 9, 2019 Started: Nov 30, 2012 Primary completion: Nov 30, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Acne Vulgaris, this trial is completed. The trial is conducted by Novan, Inc. and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Oct 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Oct 2019 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novan, Inc.

Data source: Novan, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Broomall, United States